FTC targets 'junk' patent listings on Ozempic and other drugs
The antitrust cop says that the more than 300 patent listings stall generic competition, keeping prices high for diabetes drugs, inhalers and more.
Source: livemint.com
📰 Us Pharma News
Us Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Us Pharma. Real-time updates on events, politics, business and more.